D. Albo et al., THE RELATIONSHIP OF ANGIOGENESIS TO BIOLOGICAL-ACTIVITY IN HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK, Annals of plastic surgery, 32(6), 1994, pp. 588-594
Tumor angiogenesis has recently been related to tumor growth and metas
tasis, which determine the clinical outcome of the patient. This study
was designed to determine the relationship between angiogenesis in pr
imary squamous cell carcinomas (SSC) of the head and neck and the deve
lopment of recurrent or metastatic disease, or both. Different SCC of
the head and neck were studied. Microvessels were selectively stained
using a monoclonal antibody for factor VIII. Microvessel counts were p
erformed in the tumor, in the tissues immediately adjacent, and in nor
mal tissues of similar topographies. Microvessel counts were then corr
elated with clinical outcome (development of recurrent or metastatic d
isease, or both). Recurrent or metastatic disease, or both, developed
in patients with high microvessel counts (mean, 121.25) in the tissues
adjacent to the tumor 7 to 16 months after initial treatment. Those w
ith low microvessel counts (mean, 33.75) were disease-free for 16 mont
hs to 6 years (p < 0.01). Microvessel counts inside the tumor were als
o higher in those in whom recurrences or metastasis, or both, develope
d, but were not statistically significant. In this study, angiogenesis
was directly related to clinical outcome. Thus, angiogenesis may be a
n independent predictor of recurrent or metastatic disease, or both, w
hich could help in the selection of patients with SCC of the head and
neck for aggressive therapy.